Eirgen Pharma Returns to DCAT Week 2026

Eirgen Pharma is delighted to announce our attendance at DCAT Week 2026, taking place in New York City from March 23rd to March 25th - the premier event where global pharmaceutical and biopharmaceutical leaders come together for strategic meetings, high-value collaborations, and forward-thinking industry insights.

As a trusted CDMO partner for oral solid dose products, we're looking forward to engaging with companies focused on accelerating development timelines, de-risking supply chains, and scaling commercial supply with confidence.

Building the Future of High-Potency Manufacturing

At DCAT Week, our team will highlight Eirgen's expanding capabilities across development, tech transfer, and commercial manufacturing - supported by significant investments designed to meet the industry's demand for flexible, high-quality long-term capacity.

---

Meet Our Team At DCAT 2026

Meet with members of our executive team and business development team;

• Damien Burke, Chief Executive Officer (CEO)

• James Murphy, Chief Operations Officer (COO)

• Dr. Sarah Wade, Business Development and Alliance Manager

📍 The Fitzpatrick Hotel, Manhattan

DCAT Week is all about strategic conversations - and we're ready to discuss how Eirgen can support your upcoming programs with smarter, more agile, and more resilient solutions.

Schedule time with our team to explore;

• New Product Introductions

• Expansion of Existing Supply

• Tech Transfer Opportunities

• Capacity Planning for 2026-2028

• Long-term strategic partnerships

📧 Email bd@eirgen.com to secure your meeting request.

---